Trainer P J, Lawrie H S, Verhelst J, Howlett T A, Lowe D G, Grossman A B, Savage M O, Afshar F, Besser G M
Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London, UK.
Clin Endocrinol (Oxf). 1993 Jan;38(1):73-8. doi: 10.1111/j.1365-2265.1993.tb00975.x.
We tested the hypothesis that in Cushing's disease, ACTH secretion from the normal pituitary surrounding an ACTH-secreting adenoma is inhibited and hence removal of the entire adenoma should result in an undetectable serum cortisol in the immediate post-operative period.
A retrospective study of patients undergoing transsphenoidal selective adenomectomy, hemi-hypophysectomy or total hypophysectomy for Cushing's disease at St Bartholomew's Hospital between 1985 and 1990.
Forty-eight consecutive patients (33 women, mean age 43, range 7-69 years) undergoing transsphenoidal hypophysectomy for Cushing's disease. Ten patients who underwent a second operation were re-evaluated; the patients were followed for a median time of 40 months after operation (range 15-70).
Post-operatively, serum cortisol was measured daily at 0900 h. Serum TSH, T4, prolactin, LH, FSH, testosterone or oestradiol plus plasma and urine osmolality were measured.
After initial surgery, post-operative serum cortisol was undetectable (< 50 nmol/l) in 20 out of 48 patients (42%) and < 300 nmol/l in 32 out of 48 patients (67%). Re-exploration of the pituitary fossa in 10 patients found undetectable cortisol levels in 25 (52%) and levels < 300 nmol/l in 39 (81%) patients. Cushing's syndrome has not recurred, clinically or biochemically, in any patient in whom the post-operative cortisol was < 50 nmol/l. Post-operatively, hypothyroidism was present in 40% of patients and hypogonadism in 53% of men and 30% of premenopausal women. Diabetes insipidus, persisting for at least six months, occurred in 46% of patients.
Cushing's disease has not recurred in any patient with an undetectable serum cortisol (< 50 nmol/l) post-operatively. Serum cortisol should be regarded as a tumour marker in Cushing's disease and the aim of transsphenoidal hypophysectomy for Cushing's disease should be to render the immediate post-operative serum cortisol undetectable.
我们检验了如下假设,即在库欣病中,分泌促肾上腺皮质激素(ACTH)的腺瘤周围正常垂体的ACTH分泌受到抑制,因此切除整个腺瘤应会使术后即刻血清皮质醇水平检测不到。
对1985年至1990年间在圣巴塞洛缪医院因库欣病接受经蝶窦选择性腺瘤切除术、垂体半切除术或全垂体切除术的患者进行的一项回顾性研究。
连续48例(33名女性,平均年龄43岁,范围7 - 69岁)因库欣病接受经蝶窦垂体切除术的患者。对10例接受二次手术的患者进行了重新评估;患者术后中位随访时间为40个月(范围15 - 70个月)。
术后每天09:00测量血清皮质醇。测量血清促甲状腺激素(TSH)、甲状腺素(T4)、催乳素、促黄体生成素(LH)、促卵泡生成素(FSH)、睾酮或雌二醇以及血浆和尿渗透压。
初次手术后,48例患者中有20例(42%)术后血清皮质醇检测不到(<50 nmol/L),48例患者中有32例(67%)<300 nmol/L。对10例患者的垂体窝进行再次探查发现,25例(52%)患者皮质醇水平检测不到,39例(81%)患者水平<300 nmol/L。术后皮质醇<50 nmol/L的任何患者均未出现库欣综合征的临床或生化复发。术后,40%的患者出现甲状腺功能减退,53%的男性和30%的绝经前女性出现性腺功能减退。46%的患者发生尿崩症且持续至少6个月。
术后血清皮质醇检测不到(<50 nmol/L)的任何患者均未出现库欣病复发。血清皮质醇应被视为库欣病的肿瘤标志物,经蝶窦垂体切除术治疗库欣病的目标应为使术后即刻血清皮质醇检测不到。